It costs more than $1.7 million to prevent just one additional case of active tuberculosis in a health care worker. Experts say there's a better way.

Fulvic acid (FA) is known to promote electrochemical balance as a donor or a receptor possessing many biomedical functions. Nevertheless, the effect of FA on the anti-cancer activity has not been elucidated. In the current study, we first isolated FA from humus and investigated whether FA regulates …

This article focused on the influences of fulvic acid and humic acid on aluminum speciation in drinking water. Factors including the concentration of residual chlorine and pH value had been concerned. Aluminum species investigated in the experiments included inorganic mononuclear, organic mononuclea …

The bacillus Calmette-Guérin (BCG) vaccine is one of the oldest vaccines in history and has been investigated as a potential treatment for type 1 diabetes by Dr. Denise Faustman and her team at the Massachusetts General Hospital (MGH) for over a decade. A new study published today in npj Vaccines describes the long-term outcomes of BCG administration to patients with type 1 diabetes. The study enrolled 282 individuals, 52 of whom received the vaccine. The average age of type 1 diabetes duration among the cohort was 19 years. The patients were followed for over eight years, and their A1c levels were evaluated. The study reports that patients with type 1 diabetes who received just two doses of the BCG vaccine, spaced four weeks apart, achieved markedly lower A1c levels compared to the control group. This result was observed three years after the vaccine administration and continued for the next five years […]

The delivery route and dose of the BCG vaccine profoundly alters the protective outcome after Mycobacterium tuberculosis challenge in non-human primates.

In patients with long-term type 1 diabetes, the tuberculosis vaccine BCG lowers blood sugar levels to near-normal after three years. Denise Faustman and her team from Massachusetts General Hospital and Harvard Medical School investigated a cohort of type 1 diabetics that received two doses of BCG before being monitored over eight years. After three years, vaccine-treated patients lowered their HbA1c levels—a diabetes biomarker reflecting average blood sugar over 8–12 weeks—by over 10%. This reduction increased to 18% in the fourth year, after which HbA1c levels remained low up to the final year of monitoring. The researchers report that the BCG vaccine appeared to reset diabetes-implicated parts of the immune system and, through a novel mechanism, shift glucose metabolism to lower blood sugar to healthy levels. Future studies will further classify BCG’s benefits in diabetes.

Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes - Full Text View.

The bacillus Calmette-Guérin (BCG) vaccine is the only licensed vaccine for human use against tuberculosis (TB). Although controversy exists about its efficacy, the BCG vaccine is able to protect newborns and children against disseminated forms ...

Denise Faustman, MD, PhD, is the Director of the Immunobiology Lab at Massachusetts General Hospital and an Associate Professor of Medicine at Harvard Medical School. She was interviewed by Diabetes Daily about 9 years ago when she was about to begin human clinical trials based on the results from her successful mice-curing BCG vaccine. Mice are certainly cured from type 1 diabetes a lot these days, but in clinical trials, they are often given type 1 diabetes through an interventional chemical administration. It is notable that Dr. Faustman cured mice who had naturally occurring type 1 diabetes which is rooted in the autoimmune attack on the insulin-making beta cells. The BCG vaccine, or Bacillus Calmette-Guerin vaccine, is about 100 years old and used around the world, though no longer in the United States, for the prevention of tuberculosis. It is being studied in various labs around the world due to its ability to spark the […]

Log into Facebook to start sharing and connecting with your friends, family, and people you know.

Customedica is a full-service pharmacy located in Eagle and Boise’s North End providing customized compounded medications, conventional retail prescriptions, and personal consultation in a modern, friendly environment.

CHD-FA is a promising topical remedy for drug-resistant wound infections. It accelerated the healing process of wounds infected with methicillin-resistant S. aureus and multidrug-resistant P. aeruginosa in rats, which is linked to both its antimicrobial and anti-inflammatory properties.

The bacillus Calmette-Guérin (BCG) vaccine is one of the oldest vaccines in history and has been investigated as a potential treatment for type 1 diabetes by Dr. Denise Faustman and her team at the Massachusetts General Hospital (MGH) for over a decade. A new study published today in npj Vaccines describes the long-term outcomes of BCG administration to patients with type 1 diabetes. The study enrolled 282 individuals, 52 of whom received the vaccine. The average age of type 1 diabetes duration among the cohort was 19 years. The patients were followed for over eight years, and their A1c levels were evaluated. The study reports that patients with type 1 diabetes who received just two doses of the BCG vaccine, spaced four weeks apart, achieved markedly lower A1c levels compared to the control group. This result was observed three years after the vaccine administration and continued for the next five years […]

We report a vaccine platform to express vaccine antigens on the surface of genome-reduced bacteria to enhance vaccine immunogenicity. We demonstrate the utility of this vaccine platform by expressing the highly conserved fusion peptide (FP) of SARS-CoV-2 and porcine epidemic diarrhea virus on the surface of Escherichia coli to produce killed whole-cell bacterial vaccines. The vaccine primes a potent anamnestic response, potentiates interferon-γ responses, and provides significant protection in pigs against disease following virus challenge. The FP could be a target for a broadly protective coronavirus vaccine since a betacoronavirus SARS-CoV-2 FP vaccine provided cross-protection against alphacoronavirus porcine epidemic diarrhea virus. When using a vaccine-appropriate bacteria vector, this inexpensive vaccine platform offers the potential for use in developing countries. The sequence of pRAIDA2 has been deposited into GenBank (accession no. [MW383928][1]) . All other study data are included in the article and supporting information. [1]: https://www.ncbi.nlm.nih.gov/nuccore/MW383928

Yale University is conducting a study to figure out how to best create effect "messaging" in order to convince Americans to take the upcoming C0VlD vaccine.  In reality, their methods are nothing short of manipulation.  We break them down in detail. Check out our NEW Free Speech Platform https://ISE.Media ---------------- Support Truth in Media by visiting our sponsors: ISE.Media https://ISE.Media Pulse Cellular: Use code "TRUTH" for 10% every plan for life. https://truthinmedia.com/phone Pure VPN: Military grade vpn protection. https://truthinmedia.com/vpn Brave Browser: Open source and built by a team of privacy focused, performance oriented pioneers of the web. https://truthinmedia.com/brave #benswann